Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy

This publication has 25 references indexed in Scilit:

• Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation
  The Journal of Pediatrics, 2006
• Alemtuzumab Induction and Sirolimus Plus Mycophenolate Mofetil Maintenance for CNI and Steroid‐Free Kidney Transplant Immunosuppression
  American Journal of Transplantation, 2005
• Campath-1H Use in Pediatric Renal Transplantation
  American Journal of Transplantation, 2005
• Alemtuzumab Induction and Prednisone‐Free Maintenance Immunotherapy in Kidney Transplantation: Comparison with Basiliximab Induction—Long‐Term Results
  American Journal of Transplantation, 2005
• Campath-1H in renal transplantation: The University of Wisconsin experience
  Surgery, 2004
• Present experience with Campath‐1H in organ transplantation and its potential use in pediatric recipients
  Pediatric Transplantation, 2004
• Kidney Transplantation Under a Tolerogenic Regimen of Recipient Pretreatment and Low-Dose Postoperative Immunosuppression With Subsequent Weaning
  Annals of Surgery, 2003
• RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)
  Transplantation, 2003
• Transplantation tolerance from a historical perspective
  Nature Reviews Immunology, 2001
• REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H
  The Lancet, 1988